Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy

Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy

Abstract Objective Reports of tuberculosis (TB) during anticancer treatment with immune checkpoint inhibitors (ICIs) are increasing. However, it is not clear whether the use of ICIs is a significant risk factor for TB, including reactivation or latent TB infection (LTBI). Methods To determine the ri...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Hsing-Wu Chen, Yao-Wen Kuo, Chung‐Yu Chen, Chin-Hao Chang, Sumei Wang, Ying‐Chun Chien, Wei‐Chen Lu, Jo‐Pai Chen, Cheng‐Yu Chang, Yu‐Feng Wei, Shih‐Chieh Chang, Chin‐Chung Shu, Jann‐Yuan Wang, Wei‐Yu Liao, Hao‐Chien Wang, Chong‐Jen Yu
Formaat: Artigo
Taal:Engels
Gepubliceerd in: 2024
Online toegang:https://doi.org/10.1093/oncolo/oyad340
https://academic.oup.com/oncolo/advance-article-pdf/doi/10.1093/oncolo/oyad340/56147999/oyad340.pdf
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

https://doi.org/10.1093/oncolo/oyad340
https://academic.oup.com/oncolo/advance-article-pdf/doi/10.1093/oncolo/oyad340/56147999/oyad340.pdf

Gelijkaardige items